Richard Maziarz: Where We Are and Where Cell Therapy Is Going?
Richard Maziarz, Medical Director, Blood and Marrow Transplant, Cellular Therapy Program at Oregon Health and Science University, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Transplantation and Cellular Therapy, adding:
”Where we are, where we are going?
That was the message delivered during the opening session at the Tandem meetings 2026: A summary of the CIBMTR/EBMT/ASTCT collaborative has just been published.
The work ahead is daunting but the future looks bright for cell therapy clinical care delivery.”
Title: Challenges with expansion of cell and gene therapy: A call for system-level action
Authors: Jeffery J. Auletta, Alvaro Urbano-Ispizua, Richard T. Maziarz, Anna Sureda, Sumithra Vasu, David L. Porter
Stay updated wih Hemostasis Today.
-
Aug 17, 2026, 10:26Henning Hermanns: Are We Really Making Progress in Patient Blood Management?
-
Aug 17, 2026, 10:18PPTA at BDC2026 – Advancing Plasma Donation Awareness
-
Aug 17, 2026, 10:12Jill de Mol: How Age-Associated B Cells May Worsen Atherosclerosis
-
Aug 17, 2026, 07:47Antonio Paul: Advancing Transplant Immunology Through HLA Testing
-
Aug 17, 2026, 07:34Faris Al-Radi: A Masterclass in Lipidology From ApoB to Lp(a) and Beyond
-
Aug 17, 2026, 07:17Hanaa Aldossari: Exploring Bacterial Screening of Platelet Units
-
Aug 17, 2026, 07:11Jamie Morgan: Blood Donation Number 30 in the Bag!
-
Aug 17, 2026, 07:06Lindsey Kerr Piersol: You Never Think You’ll Need a Transfusion Until You Do
-
Aug 17, 2026, 06:50Edward Lee Carter: Why ‘Never Again’ Might Be the Wrong Instinct After Intracerebral Hemorrhage